Ron Bentsur Nuvectis Pharma, Inc. (NVCT) insider trading activity
Ron Bentsur is Chairman & CEO of Nuvectis Pharma, Inc.. Currently has a direct ownership of 3.25 Million shares of NVCT, which is worth approximately $19.8 Million. The most recent transaction as insider was on Jun 24, 2022, when has been sold 400 shares (Common Stock) at a price of $12.18 per share, resulting in proceeds of $4,872. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.25M
0%
3M change
0.32%
12M change
Total Value Held
$19.8 Million
RON BENTSUR Transaction History
Also insider at
RB
Ron Bentsur
Chairman & CEO
Garden City, NY